About Shandong Buchang Pharmaceuticals Co., Ltd.
Shandong Buchang Pharmaceuticals, part of the Buchang group founded in 1993, is one of China's largest patented Chinese medicine companies, with a leading position in treating cardiovascular and cerebrovascular diseases. Its main production base is located in Heze, Shandong.
Its flagship product, Danhong injection, ranks among the country's best-selling patented Chinese medicines, alongside capsules and other preparations for cardiology, neurology, diabetes and women's health. The company has promoted modern clinical research standards to validate the efficacy of its traditional formulas.
Buchang combines large-scale production with a commercial network covering hospitals across China and a growing presence in overseas markets. For the sector, it represents the model of a Chinese pharmaceutical company industrialising traditional medicine to contemporary pharmaceutical standards.
Its flagship product, Danhong injection, ranks among the country's best-selling patented Chinese medicines, alongside capsules and other preparations for cardiology, neurology, diabetes and women's health. The company has promoted modern clinical research standards to validate the efficacy of its traditional formulas.
Buchang combines large-scale production with a commercial network covering hospitals across China and a growing presence in overseas markets. For the sector, it represents the model of a Chinese pharmaceutical company industrialising traditional medicine to contemporary pharmaceutical standards.